What's New in the Management of Pancreatic Cancer? (C)

This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer. Learn more about ACS Accreditation/Verification Requirements.

Session Description

Though a deadly disease, there have been numerous advances in the care of the pancreatic cancer patient. This session will cover the latest information in imaging the patient preoperatively, the use of neoadjuvant therapy, and new techniques in surgery.

Moderator: Robert C. Martin, MD, FACS, Louisville, KY

Co-Moderator: Vinod Balachandran, MD, FACS, New York, NY


Surgical Quality in Pancreatectomy: Whipple and Distal Pancreatectomy
Syed A. Ahmad, MD, FACS, Cincinnati, OH

The Use of Molecular Subtyping: Should All Newly Diagnosed Pancreatic Ductal Adenocarcinoma (PDA) undergo Subtyping?
Jen Jen Yeh, MD, FACS, Chapel Hill, NC

Pancreatectomy Technique: Robotic vs. Lap vs. Open
Steven J. Hughes, MD, FACS, Gainesville, FL

Surgeons and Pancreatic Cancer Clinical Trials: How to Lead and Initiate a Pancreatic Clinical Trial
David K. Chang, MD, Glasgow, United Kingdom

Sponsored by the Advisory Council for General Surgery and the Commission on Cancer

Target Audience

  • Practicing surgeons
  • Residents

Learning Objectives

  • Apply new knowledge and ideas to improve their surgical practice
  • Adapt concepts and quality measures in support of research advancements
  • Enhance the quality of patient care


For questions about the course, please contact elearning@facs.org.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Completion
  • 1.50 Self Assessment Credit
Course opens: 
Course expires: 

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.

(Download the full list of disclosures).

Faculty and Disclosures

David K. Chang, MBBS, MS, FRACS, FRCS(Glasg), PhD - Celgene: Investigator Initiated Clnical Trial research funding support: Translational Chief Investigator of Investigator Initiated Trial
Jen Jen Yeh MD, FACS - Nothing to Disclose
Robert C. Martin MD, FACS - Nothing to Disclose
Steven J. Hughes MD, FACS - Nothing to Disclose
Syed A. Ahmad, MD, FACS - Abbvie Inc.: Honorarium: Speaker Bureau; Portola (Andexxa): Honoraria: Speakers Bureau
Vinod Balachandran, MD, FACS - Bristol Myers Squibb: Research funding:

Program Committee and Disclosures

CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure


David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure


Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure


Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure

Continuing Medical Education Credit Information


The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 1.5 credits meets the requirements for Self-Assessment.

American College of Surgeons and ACGME Logos

Note: Residents will receive a Certificate of Completion.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Completion
  • 1.50 Self Assessment Credit
Please login or register to take this course.

This course is available as part of the Clinical Congress 2019 Webcast Packages